| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 333.16× | 333.16× | 487.39× | 640.19× | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 55.64× | 55.64× | 53.83× | 41.43× | 39.44× | ||
| 10,928.10× | 10,928.10× | 16,408.90× | 12,863.10× | — | ||
| −10,539.30× | −10,539.30× | −15,867.68× | −12,181.48× | — | ||
| −4.57× | −4.71× | −4.13× | −3.83× | −3.75× | ||
| 1.14× | 1.14× | 1.10× | 1.11× | 1.05× | ||
| 29.15× | 29.15× | 9.14× | 4.06× | 4.68× | ||
| 0.89× | 0.89× | 1.04× | 0.95× | 1.25× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | — | 640.19 | 487.39 | 333.16 | 333.16 | |
| Receivable Days (DSO) | 39.44 | 41.43 | 53.83 | 55.64 | 55.64 | |
| Payable Days (DPO) | — | 12,863.10 | 16,408.90 | 10,928.10 | 10,928.10 | |
| Cash Conversion Cycle (days) | — | -12,181.48 | -15,867.68 | -10,539.30 | -10,539.30 | |
| Working Capital Turnover | -3.75 | -3.83 | -4.13 | -4.71 | -4.57 | |
| Asset Turnover | 1.05 | 1.11 | 1.10 | 1.14 | 1.14 | |
| Cash Conversion (CFO/Net Income) | 4.68 | 4.06 | 9.14 | 29.15 | 29.15 | |
| CFO/EBITDA | 1.25 | 0.95 | 1.04 | 0.89 | 0.89 |